Epilepsy carries a heavy burden in Rwanda, as it does in many other societies around the world, as the condition is shrouded in stigma, fear, and widespread misunderstanding, leaving patients and their loved ones isolated and struggling.
Health authorities expect the vaccination programme to commence in 2026, marking a significant expansion of the country’s cervical cancer prevention efforts.
The partnership will bring more than 230 advanced medical systems to 19 public hospitals throughout the country.
The introduction of lenacapavir will expand rather than replace current prevention methods available in Rwanda.
The approved funding will help countries build systems that keep communities safe, particularly in cross-border areas where health risks are highest.